Clinical Research Directory
Browse clinical research sites, groups, and studies.
Head to Head Trial of Mailed Cologuard to Mailed FIT
Sponsor: University of California, San Diego
Summary
The objective of this study is to measure the comparative effectiveness of mailed outreach of two stool based tests, multi-target stool DNA (Cologuard) and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.
Official title: Comparative Effectiveness of Mailed Cologuard Outreach to Mailed FIT Outreach
Key Details
Gender
All
Age Range
45 Years - 49 Years
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2025-09-05
Completion Date
2027-09
Last Updated
2025-09-09
Healthy Volunteers
No
Conditions
Interventions
Cologuard
Multi-target stool DNA test for colorectal cancer screening implemented by Exact Sciences. Cologuard has 94% sensitivity and 87% specificity to detect colorectal cancer.
Fecal Immunochemical Test
Stool blood test for colorectal cancer screening. FIT has 75% sensitivity and 90% specificity to detect colorectal cancer.
Locations (1)
University of California San Diego
La Jolla, California, United States